LONDON (Reuters) - The World Health Organization has agreed a no-fault compensation plan for claims of serious side effects in people in 92 poorer countries due to get COVID-19 vaccines via the COVAX sharing scheme, resolving a big concern among recipient governments.
USC researchers have developed a new method to counter emergent mutations of the coronavirus and hasten vaccine development to stop the pathogen responsible for killing thousands of people and ruining the economy.
As new COVID-19 variants emerge that are potentially more contagious, specialists say that masks are more important than ever because they will lower the spread of the virus regardless of the variant.
While the push to get Americans vaccinated continues across the country, preliminary data has emerged that lab-created monoclonal antibodies could be a treatment for COVID-19.
Vaccination centers in Europe are standing ready — but no vaccine is available. Pfizer has cut its production, and AstraZeneca has announced it would be delivering 60% less than agreed with the EU.